Tetanus in Emergency Medicine Clinical Presentation
- Author: Daniel J Dire, MD, FACEP, FAAP, FAAEM; Chief Editor: Rick Kulkarni, MD more...
History
From 1995-2000, 81% of cases in the United States were generalized tetanus, 15% were localized, 3% were cephalic, and 1 case of neonatal tetanus was reported.
Almost all reported cases of tetanus are in persons who have either never been vaccinated or who completed a primary series but have not had a booster in the preceding 10 years. From 1995-1997, 54% of the reported cases in the United States had an unknown tetanus vaccination history, 22% had no known previous tetanus vaccination, 9% had 1 previous dose, 3% had 2 previous doses, 3% had 3 previous doses, and 9% had 4 or more previous doses.
The median incubation period is 7 days, and, for most cases (73%), incubation ranges from 4-14 days.
- The incubation period is shorter than 4 days in 15% of cases and longer than 14 days in 12% of cases.
- Patients with clinical manifestations occurring within 1 week of an injury have more severe clinical courses.
Patients with generalized tetanus present with trismus (ie, lockjaw) in 75% of cases.
- Other presenting complaints include stiffness, neck rigidity, dysphagia, restlessness, and reflex spasms.
- Subsequently, muscle rigidity becomes the major manifestation.
- Muscle rigidity spreads in a descending pattern from the jaw and facial muscles over the next 24-48 hours to the extensor muscles of the limbs.
- Dysphagia occurs in moderately severe tetanus due to pharyngeal muscle spasms, and onset is usually insidious over several days.
- Reflex spasms develop in most patients and can be triggered by minimal external stimuli such as noise, light, or touch. The spasms last seconds to minutes; become more intense; increase in frequency with disease progression; and can cause apnea, fractures, dislocations, and rhabdomyolysis.
- Laryngeal spasms can occur at any time and can result in asphyxia.
- Other symptoms include elevated temperature, sweating, elevated blood pressure, and episodic rapid heart rate.
Sustained contraction of facial musculature produces a sneering grin expression known as risus sardonicus.
Physical
The lower extremity is the site of antecedent acute injury in 52% of patients, the upper extremity is the site of antecedent injury in 34% of patients, and head or trunk is the site of antecedent injury in 5% of patients.
Autonomic dysfunction in patients with severe tetanus manifests as extremes in blood pressure, dysrhythmias, and cardiac arrest.
Neonatal tetanus presents with an inability to suck 3-10 days after birth. Presenting symptoms include irritability, excessive crying, grimaces, intense rigidity, and opisthotonus.
Tetanic seizures may occur and portend a poor prognosis.
- Frequency and severity of seizures are related to severity of the disease.
- Seizures resemble epileptic seizures with the presence of a sudden burst of tonic contractions.
- However, the patient does not lose consciousness and usually experiences severe pain.
- Seizures frequently occur in the muscle groups causing opisthotonos, flexion and abduction of the arms, clenching of the fists against the thorax, and extension of the lower extremities.
Localized tetanus is characterized by painful spasms of the group of muscles in close proximity to the site of injury. This disorder may persist for several weeks but is usually self-limiting.
Cephalic tetanus is a rare form of the disease that is usually secondary to chronic otitis media or head trauma.
- Cephalic tetanus is characterized by variable cranial nerve (CN) palsies; CN VII is most frequently involved.
- Ophthalmoplegic tetanus is a variant that develops after penetrating eye injuries and results in CN III palsies and ptosis.
- Patients with cephalic tetanus who are untreated progress to generalized tetanus.
Patients with tetanus may present with abdominal tenderness and guarding, mimicking an acute abdomen. Exploratory laparotomies have been performed before the correct diagnosis was apparent.
Tetanospasmin has a disinhibitory effect on the autonomic nervous system (ANS).
- ANS dysfunction becomes progressively evident as the level of toxin in the CNS increases.
- ANS disturbances, such as sweating, fluctuating blood pressure, episodic tachydysrhythmia, and increased release of catecholamines, are observed.
- Drugs with beta-blocker effects have been used to control the cardiovascular manifestations of ANS instability, but they also have been associated with increased risk of sudden death.
Causes
Only 12-14% of patients with tetanus in the United States have received a primary series of tetanus toxoid. During 1998-2000, only 6% of all patients with tetanus were known to be current with tetanus immunization, with no fatal cases reported among this group.[1]
- In 73% of patients with tetanus in the United States, tetanus occurred after an acute injury, including puncture wounds (50%), lacerations (33%), and abrasions (9%).
- Of those who obtained medical treatment of their injury in the United States from 1998-2000, 96% were administered tetanus immune globulin as part of their treatment; 55% of patients required the use of assisted ventilation and 31% of these patients died.
- Stepping on a nail accounted for 32% of the puncture wounds.
- Tetanus can occur in burn victims; in patients receiving intramuscular injections; in persons obtaining a tattoo; and in persons with frostbite, dental infections (eg, periodontal abscesses), penetrating eye injuries, and umbilical stump infections.
- Other reported risk factors include diabetes, chronic wounds (eg, skin ulcers, abscesses, gangrene), parenteral drug abuse, and recent surgery (4% of US cases).
- Twelve percent of patients with tetanus in the United States from 1998-2000 had diabetes (with a mortality rate of 31%) compared with 2% during 1995-1997. Of these patients, 69% had acute injuries, while 25% had gangrene or a diabetic ulcer.
- The median time interval between surgery and onset of tetanus is 7 days.
- Tetanus has been reported after tooth extractions, root canal therapy, and intraoral soft tissue trauma.
Worldwide risk factors for neonatal tetanus are as follows:
- Unvaccinated mother, home delivery, and unhygienic cutting of the umbilical cord increase susceptibility to tetanus.
- History of neonatal tetanus in a previous child is a risk factor for subsequent neonatal tetanus.
- Potentially infectious substances applied to the umbilical stump (eg, animal dung, mud, clarified butter) are risk factors for neonates.
Immunity from tetanus decreases with advancing age.
- Serologic testing for immunity has revealed a low level among elderly individuals in the United States.
- Approximately 50% of adults older than 50 years are nonimmune because they never were vaccinated or do not receive appropriate booster doses.
- Prevalence of immunity to tetanus in the United States is greater than 80% for those aged 6-39 years but only 28% for persons older than 70 years.
Pascual FB, McGinley EL, Zanardi LR, et al. Tetanus surveillance--United States, 1998--2000. MMWR Surveill Summ. Jun 20 2003;52(3):1-8. [Medline].
Apte NM, Karnad DR. Short report: the spatula test: a simple bedside test to diagnose tetanus. Am J Trop Med Hyg. Oct 1995;53(4):386-7. [Medline].
World Health Organization. WHO Technical Note: Current recommendations for treatment of tetanus during humanitarian emergencies. January 2010. [Full Text].
Thwaites CL, Yen LM, Loan HT, Thuy TT, Thwaites GE, Stepniewska K. Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. Lancet. Oct 21 2006;368(9545):1436-43. [Medline].
Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J (Clin Res Ed). Sep 7 1985;291(6496):648-50. [Medline].
Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep. Dec 15 2006;55(RR-17):1-37. [Medline].
Hatamabadi HR, Abdalvand A, Safari S, Kariman H, Dolatabadi AA, Shahrami A, et al. Tetanus Quick Stick as an applicable and cost-effective test in assessment of immunity status. Am J Emerg Med. Sep 2011;29(7):717-20. [Medline].
Bardenheier B, Prevots DR, Khetsuriani N, et al. Tetanus surveillance--United States, 1995-1997. MMWR CDC Surveill Summ. Jul 3 1998;47(2):1-13. [Medline].
Checketts MR, White RJ. Avoidance of intermittent positive pressure ventilation in tetanus with dantrolene therapy. Anaesthesia. Nov 1993;48(11):969-71. [Medline].
Galazka A, Gasse F. The present status of tetanus and tetanus vaccination. Curr Top Microbiol Immunol. 1995;195:31-53. [Medline].
Groleau G. Tetanus. Emerg Med Clin North Am. May 1992;10(2):351-60. [Medline].
Izurieta HS, Sutter RW, Strebel PM, et al. Tetanus surveillance--United States, 1991-1994. MMWR CDC Surveill Summ. Feb 21 1997;46(2):15-25. [Medline].
Kefer MP. Tetanus. Am J Emerg Med. Sep 1992;10(5):445-8. [Medline].
Knight AL, Richardson JP. Management of tetanus in the elderly. J Am Board Fam Pract. Jan-Feb 1992;5(1):43-9. [Medline].
Murphy SM, Hegarty DM, Feighery CS, et al. Tetanus immunity in elderly people. Age Ageing. Mar 1995;24(2):99-102. [Medline].
Richardson JP, Knight AL. The management and prevention of tetanus. J Emerg Med. Nov-Dec 1993;11(6):737-42. [Medline].
Saissy JM, Demaziere J, Vitris M, et al. Treatment of severe tetanus by intrathecal injections of baclofen without artificial ventilation. Intensive Care Med. 1992;18(4):241-4. [Medline].
Sanders RK. The management of tetanus 1996. Trop Doct. Jul 1996;26(3):107-15. [Medline].
Wassilak SGF, Roper MH, Murphy TV, Orenstein WA. Tetanus. In: Plotkin SA, Orenstein WA, eds. Vaccines. 4th ed. Philadelphia, Pa: Saunders; 2003:745-81.

